Xspray Pharma AB (publ) (XSPRAY) Says CML Data Support Differentiation of Dasynoc and Nilopki

Xspray Pharma will present posters indicating significantly lower exposure variability for Dasynoc and reduced food effect for Nilopki, supporting differentiated profiles of its HyNap-based CML candidates.Material DetailsContext by AI AnalystThis is an incremental validation of Xspray’s HyNap refor…